With the Roche (RHHBY.PK) acquisition of Genentech (DNA), investors are wondering if the big pharmaceutical companies are the medicine that their portfolios need. Especially if those companies have high yields. WallStreetNewsNetwork.com recently came out with its downloadable Excel database of High Yield Big Pharma stocks, more than half of which have yields over 4%. Here are a few examples:
Novartis AG (NVS) is the Swiss based healthcare products company, which has a PE ratio of 12, and yields 4.10%.
Merck & Co., Inc. (MRK) is the New Jersey based pharma that makes Singulair, Zocor, Propecia, Proscar, Gardasil and numerous other products. They have a PE ratio of 8, and yields 5.10%.
GlaxoSmithKline plc (GSK) is the British based pharmaceutical and consumer health-related products company, which sells Advair, Advair, Zofran, Valtrex, Flovent and many other pharmaceuticals, along with many over-the-counter products. They have a PE ratio of 14, and a yield of 5.60%.
To see a list of all the big pharmas and their yields which can be downloaded, sorted, and changed, go to wsnn.com.
Author does not own any of the above.